Single-lung Transplant in a Patient with <i>Mycobacterium avium</i> Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension

A 55-year-old man presented to our hospital with idiopathic pulmonary fibrosis (IPF). He was registered with the Japan Organ Transplant Network the following year due to disease progression. Treatment with clarithromycin, ethambutol, and rifampicin for complications of Mycobacterium avium pulmonary disease was initiated, but sputum conversion could not be achieved. The administration of an amikacin liposome inhalation suspension (ALIS) resulted in sputum conversion, and single-lung transplantation was performed. ALIS therapy was continued after lung transplantation, and no M. avium disease was observed for 15 months. ALIS may cause M. avium pulmonary disease with additional indications for lung transplantation.

Authors

Institutions

Publication Details

Journal
Internal Medicine
Published
2024-09-10
DOI
https://doi.org/10.2169/internalmedicine.3854-24
Citations
2
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.77
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension

Kadoaki Ohashi, Kiichiro Ninomiya, Shinichi Toyooka, Go Makimoto et al.
2 citations
Internal Medicine
Mycobacterium research and diagnosis
0.77
article

Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension

Kadoaki Ohashi, Kiichiro Ninomiya, Shinichi Toyooka, Go Makimoto, Shunta Mori, Eiki Ichihara, Akihiko Taniguchi, Kammei Rai, Katsuyuki Hotta, Shin Tanaka, Hisao Higo, Seiichiro Sugimoto, Yoshinobu Maeda, Masahiro Tabata, Nobuaki Miyahara, Masanori Fujii, Kentaro Miyoshi, Taichi Ozeki, Hiroki Omori
article en
2 citations

Abstract

A 55-year-old man presented to our hospital with idiopathic pulmonary fibrosis (IPF). He was registered with the Japan Organ Transplant Network the following year due to disease progression. Treatment with clarithromycin, ethambutol, and rifampicin for complications of Mycobacterium avium pulmonary disease was initiated, but sputum conversion could not be achieved. The administration of an amikacin liposome inhalation suspension (ALIS) resulted in sputum conversion, and single-lung transplantation was performed. ALIS therapy was continued after lung transplantation, and no M. avium disease was observed for 15 months. ALIS may cause M. avium pulmonary disease with additional indications for lung transplantation.

Internal MedicineVol. 64(7)
Okayama University (JP), Okayama University Hospital (JP), Fukuyama Cardiovascular Hospital (JP), National Hospital Organization (JP)
Good health and well-being
Openalex Percentile: Top 26%
Mycobacterium research and diagnosis
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.